治疗糖尿病药物及生物制品临床试验指导原则

2019-10-31 国家药品监督管理局药品审评中心(CDE)

治疗糖尿病药物及生物制品临床试验指导原则

中文标题:

治疗糖尿病药物及生物制品临床试验指导原则

发布日期:

2019-10-31

简要介绍:

治疗糖尿病药物及生物制品临床试验指导原则

相关资料下载:
[AttachmentFileName(sort=100, fileName=治疗糖尿病药物及生物制品临床试验指导原则)] GetToolGuiderByIdResponse(projectId=1, id=193281c001818193, title=治疗糖尿病药物及生物制品临床试验指导原则, enTitle=, guiderFrom=, authorId=null, author=, summary=治疗糖尿病药物及生物制品临床试验指导原则, cover=, journalId=null, articlesId=null, associationId=1936, associationName=国家药品监督管理局药品审评中心(CDE), associationIntro=国家药品监督管理局药品审评中心(CDE), copyright=0, guiderPublishedTime=Thu Oct 31 05:44:23 CST 2019, originalUrl=, linkOutUrl=, content=治疗糖尿病药物及生物制品临床试验指导原则, tagList=[TagDto(tagId=216, tagName=糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=67, categoryName=研究设计与统计, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5712, appHits=267, showAppHits=11, pcHits=2893, showPcHits=4307, likes=106, shares=7, comments=2, approvalStatus=1, publishedTime=Thu Oct 31 05:44:23 CST 2019, publishedTimeString=2019-10-31, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=fbzhang, createdTime=Thu Oct 31 05:44:23 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:58:51 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=治疗糖尿病药物及生物制品临床试验指导原则)])
治疗糖尿病药物及生物制品临床试验指导原则
下载请点击:
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=805681, encodeId=5a1f805681a4, content=打不开, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89a55221541, createdName=1477efb7m89暂无昵称, createdTime=Sun Aug 02 01:24:49 CST 2020, time=2020-08-02, status=1, ipAttribution=)]
    2020-08-02 1477efb7m89暂无昵称

    打不开

    0